Loading...
Scholar Rock Holding Corporation
SRRK•NASDAQ
Healthcare
Biotechnology
$47.70
$-0.30(-0.62%)
U.S. Market opens in 9h 46mScholar Rock Holding Corporation (SRRK) AI-Powered Stock Analysis
See how Scholar Rock Holding Corporation scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerScholar Rock Holding Corporation (SRRK) Stock Overall Grade
Scholar Rock Holding Corporation’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Scholar Rock Holding Corporation's overall stock rating.
Forecast
A+Score
94/100Financial Growth
BScore
60/100Fundamental Growth
C+Score
56/100Key Ratios
C+Score
55/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
95/100Analyst Consensus
B+Score
75/100Scholar Rock Holding Corporation (SRRK) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 94/100 (A+), reflecting high confidence in its potential. Financial Growth (60/100, B) and Fundamental Growth (56/100, C+) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (95/100, A+), it shows competitive strength. Analyst Consensus (75/100,B+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Scholar Rock Holding Corporation stock grade, including financials, comparisons, and forecasts.